Mapping the multiple prodrome: symptoms, diagnosis, and prognosis

Award Details: The Defense Health Agency (DHA) awarded a $305,829 Project Grant to Karolinska Institutet on September 1, 2025, under the Military Medical Research and Development program (CFDA 12.420). The award supports a two-year performance period through August 31, 2027, for research conducted in Sweden.

Products and Services: Karolinska Institutet will deliver advanced biomedical research services focused on "Mapping the Multiple Prodrome: Symptoms, Diagnosis, and Prognosis." As a prestigious international research institution with extensive expertise in genomics, neuroscience, immunology, and complex medical research, the awardee will conduct hypothesis-driven research investigating the prodromal phase of disease conditions to advance understanding of early symptoms, diagnostic criteria, and prognostic indicators. This research aligns with the DHA's Military Medical Research and Development program objectives to support transformative healthcare solutions for military service members and the American public through innovative medical investigations addressing critical health challenges. The institution will leverage its collaborative research capabilities and established partnerships with U.S. academic medical centers to deliver comprehensive research findings and translational outputs throughout the award period.